journal
https://read.qxmd.com/read/38433351/comparison-of-migraine-with-left-versus-right-sided-headache-a-cross-sectional-study
#21
JOURNAL ARTICLE
Adam S Sprouse Blum, Lauren A DaSilva, Michael D Greenberg, Alexander J Nissenbaum, Robert E Shapiro, Benjamin Littenberg
OBJECTIVE: The goal of this study was to clarify whether clinical differences exist between patients with migraine who experience headache that is typically left-sided ("left-migraine") versus right-sided ("right-migraine") during attacks. BACKGROUND: Migraine has been associated with unilateral headache for millennia and remains a supportive trait for the clinical diagnosis of migraine of the International Classification of Headache Disorders. It is currently unknown why headache in migraine is commonly unilateral, and whether headache-sidedness is associated with other clinical features...
March 3, 2024: Headache
https://read.qxmd.com/read/38429974/cerebrovascular-reactivity-to-hypercapnia-in-patients-with-migraine-a-dual-echo-arterial-spin-labeling-mri-study
#22
JOURNAL ARTICLE
E S Hoogeveen, N Pelzer, E Ghariq, M J P van Osch, A Dahan, G M Terwindt, M C Kruit
OBJECTIVE: This study aimed to compare cerebrovascular reactivity between patients with migraine and controls using state-of-the-art magnetic resonance imaging (MRI) techniques. BACKGROUND: Migraine is associated with an increased risk of cerebrovascular disease, but the underlying mechanisms are still not fully understood. Impaired cerebrovascular reactivity has been proposed as a link. Previous studies have evaluated cerebrovascular reactivity with different methodologies and results are conflicting...
March 2, 2024: Headache
https://read.qxmd.com/read/38413540/a-randomized-open-label-5-period-crossover-study-evaluating-the-pharmacokinetics-and-safety-of-a-single-dose-of-intranasal-dihydroergotamine-dhe-powder-sts101-intramuscular-dhe-mesylate-and-liquid-nasal-spray-dhe-in-healthy-adults
#23
JOURNAL ARTICLE
Richard B Lipton, Detlef Albrecht, Maria Bermudez, Jerry Hu, Elizabeth Hussey, Jeff Levy
OBJECTIVE: To compare the safety and pharmacokinetics (PK) of dihydroergotamine (DHE) after administration of intranasal DHE powder (STS101), liquid nasal spray (LNS) DHE mesylate, and intramuscular (IM) DHE mesylate injection in healthy participants. BACKGROUND: DHE is an effective acute migraine treatment; however, self-administration difficulties have prevented its broader role in the management of migraine. METHODS: This randomized, active-controlled, five-period crossover study was conducted over 5 weeks separated by 1-week washout periods...
February 27, 2024: Headache
https://read.qxmd.com/read/38413511/characteristics-of-acute-ischemic-stroke-and-unusual-aura-in-patients-with-migraine-with-aura
#24
JOURNAL ARTICLE
Adrian Scutelnic, Nathalie L Sutter, Morin Beyeler, Thomas R Meinel, Franz Riederer, Urs Fischer, Marcel Arnold, Heinrich P Mattle, Simon Jung, Christoph J Schankin
BACKGROUND: Sometimes migraine aura changes from attack to attack, raising the question of whether the change is heralding an ischemic stroke or an unusual aura. Differentiating unusual migraine aura from the onset of an acute ischemic stroke in patients with migraine with aura (MwA) can be challenging. OBJECTIVE: The aim of this cohort study was to assess clinical characteristics that help distinguish between MwA and minor stroke in patients with a previous history of MwA who presented with suspicion of stroke...
February 27, 2024: Headache
https://read.qxmd.com/read/38407505/correction-to-once-daily-oral-atogepant-for-the-long-term-preventive-treatment-of-migraine-findings-from-a-multicenter-randomized-open-label-phase-3-trial
#25
(no author information available yet)
No abstract text is available yet for this article.
February 26, 2024: Headache
https://read.qxmd.com/read/38385703/beyond-myths-transformative-insights-into-spinal-cerebrospinal-fluid-leaks-and-their-role-in-persistent-headache-syndromes
#26
EDITORIAL
Ian Carroll, Andrew L Callen
No abstract text is available yet for this article.
February 22, 2024: Headache
https://read.qxmd.com/read/38385697/anti-neutrophil-cytoplasmic-antibody-associated-vasculitis-with-headache-and-stroke-as-the-main-symptoms-a-case-report
#27
Xiaoyu Wu, Xiao Liu, Le Liu, Xiangqi Cao, Mengyuan Zhang, Sifan Wang, Meiying Deng, Guogang Luo, Qiumin Qu, Yitong Bian, Fude Liu, Jing Luo, Suhang Shang
No abstract text is available yet for this article.
February 22, 2024: Headache
https://read.qxmd.com/read/38385629/synergistic-effect-of-combining-dual-enkephalinase-inhibitor-pl37-and-sumatriptan-in-a-preclinical-model-of-migraine
#28
JOURNAL ARTICLE
Jeanne Rossignol, Tanja Ouimet, Hervé Poras, Radhouane Dallel, Philippe Luccarini
OBJECTIVE: The aim of this study was to test whether a combination of sumatriptan with dual enkephalinase inhibitor PL37 would result in an additive or a synergistic effect. BACKGROUND: Combination treatment is frequently used to improve the therapeutic efficacy of drugs. The co-administration of two drugs may result in efficacy at lower doses than those needed for either drug alone, thus minimizing side effects. Here, we tested the effect of the co-administration of two drugs on cutaneous mechanical hypersensitivity (MH), a symptom often affecting cephalic regions in patients with migraine: dual enkephalinase inhibitor PL37, a small molecule that protects enkephalins from rapid degradation, and sumatriptan, a serotonin 5-HT1B/1D receptor agonist...
February 22, 2024: Headache
https://read.qxmd.com/read/38318677/habitual-caffeinated-beverage-consumption-and-headaches-among-adults-with-episodic-migraine-a-prospective-cohort-study
#29
JOURNAL ARTICLE
Maggie R Mittleman, Elizabeth Mostofsky, Angeliki Vgontzas, Suzanne M Bertisch
OBJECTIVE: To examine the relationship between habitual caffeinated beverage consumption and headache frequency, duration, and intensity in a prospective cohort of adults with episodic migraine. BACKGROUND: Caffeine is a commonly ascribed headache trigger in adults with migraine and clinicians may counsel patients to avoid caffeinated beverages; however, few studies have examined this association. METHODS: From March 2016 to August 2017, 101 adults with physician-confirmed episodic migraine completed baseline questionnaires, including information about caffeinated beverage consumption...
February 6, 2024: Headache
https://read.qxmd.com/read/38288634/regulation-of-headache-response-and-transcriptomic-network-by-the-trigeminal-ganglion-clock
#30
JOURNAL ARTICLE
Chorong Han, Ji Ye Lim, Nobuya Koike, Sun Young Kim, Kaori Ono, Celia K Tran, Elizaveta Mangutov, Eunju Kim, Yanping Zhang, Lingyong Li, Amynah A Pradhan, Kazuhiro Yagita, Zheng Chen, Seung-Hee Yoo, Mark J Burish
OBJECTIVE: To characterize the circadian features of the trigeminal ganglion in a mouse model of headache. BACKGROUND: Several headache disorders, such as migraine and cluster headache, are known to exhibit distinct circadian rhythms of attacks. The circadian basis for these rhythmic pain responses, however, remains poorly understood. METHODS: We examined trigeminal ganglion ex vivo and single-cell cultures from Per2::LucSV reporter mice and performed immunohistochemistry...
January 30, 2024: Headache
https://read.qxmd.com/read/38284247/effect-of-prednisolone-for-the-treatment-of-medication-overuse-headache-a-3-month-result-from-a-multicenter-registry-for-load-and-management-of-medication-overuse-headache-release-study
#31
JOURNAL ARTICLE
Mi Ji Lee, Hong-Kyun Park, Sun-Young Oh, Jin-Ju Kang, Yooha Hong, Heui-Soo Moon, Tae-Jin Song, Min Kyung Chu, Soo-Jin Cho
OBJECTIVE: To evaluate the efficacy of prednisolone in the treatment of medication-overuse headache (MOH) using data from a multicenter prospective registry (Registry for Load and Management of Medication Overuse Headache [RELEASE]). BACKGROUND: The treatment of MOH is challenging, especially when withdrawal headache manifests during the cessation of overused medication. Although systemic corticosteroids have been empirically used to reduce withdrawal headaches, their efficacy on the long-term outcomes of MOH has not been documented...
January 29, 2024: Headache
https://read.qxmd.com/read/38284241/neuromodulation-for-primary-headache-disorders-advantages-and-challenges
#32
JOURNAL ARTICLE
Crystal Jicha, Kendra Pham
No abstract text is available yet for this article.
January 29, 2024: Headache
https://read.qxmd.com/read/38284213/daith-piercing-revisited-from-the-perspective-of-auricular-acupuncture-systems-a-narrative-review
#33
REVIEW
Saroj K Pradhan, Andreas R Gantenbein, Yiming Li, Hamdy Shaban, Xiaoying Lyu, Ahmet Sevik, Michael Furian
BACKGROUND: Daith piercing is a special ear-piercing method that punctures the crus of the helix. The penetrated site at the ear's innermost point is assumed to stimulate a pressure point associated with the vagus nerve. It has been reported that the pierced spot relieves migraine and tension-type headaches by activating vagal afferents, leading to the inhibition of neurons in the caudal trigeminal nucleus via the nucleus tractus solitarii. OBJECTIVE: The objective of this narrative literature review is to summarize the current state of knowledge concerning daith piercing for the treatment of migraine and tension-type headaches from the perspectives of the Chinese and Western auricular systems...
January 29, 2024: Headache
https://read.qxmd.com/read/38644702/the-effectiveness-of-parenteral-agents-for-pain-reduction-in-patients-with-migraine-presenting-to-emergency-settings-a%C3%A2-systematic-review-and-network-analysis
#34
REVIEW
Scott W Kirkland, Lloyd Visser, Jillian Meyer, Daniela R Junqueira, Sandra Campbell, Cristina Villa-Roel, Benjamin W Friedman, Nana Owusu Essel, Brian H Rowe
OBJECTIVES: To assess the comparative effectiveness and safety of parenteral agents for pain reduction in patients with acute migraine. BACKGROUND: Parenteral agents have been shown to be effective in treating acute migraine pain; however, the comparative effectiveness of different approaches is unclear. METHODS: Nine electronic databases and gray literature sources were searched to identify randomized clinical trials assessing parenteral agents to treat acute migraine pain in emergency settings...
April 2024: Headache
https://read.qxmd.com/read/38525797/impact-of-ramadan-fasting-on-vision-and-headache-related-quality-of-life-in-women-with-idiopathic-intracranial-hypertension-a-prospective-observational-study
#35
JOURNAL ARTICLE
Mona Hussein, Mohamed Abdelghaffar, Mona Ali, Abdelhady M Yassein, Doaa M Khalil, Rehab Magdy
BACKGROUND: Ramadan fasting is an obligatory religious practice for Muslims. However, research data on the effect of Ramadan on idiopathic intracranial hypertension (IIH) symptoms are lacking. This study aimed to study the effect of Ramadan fasting on the severity of headache and visual symptoms and related quality-of-life activities. METHODS: This prospective cohort study targeted females diagnosed with IIH (n = 102) who were eligible to fast for Ramadan in 2023...
April 2024: Headache
https://read.qxmd.com/read/38504449/preliminary-prospective-observational-investigation-of-clinical-outcomes-among-treatment-seeking-youth-with-continuous-headache
#36
LETTER
Robert C Gibler, Kaelynn E Knestrick, Scott W Powers, Andrew D Hershey, Marielle Kabbouche, Joanne Kacperski, Brooke L Reidy
No abstract text is available yet for this article.
March 2024: Headache
https://read.qxmd.com/read/38429985/low-pulse-pressure-and-high-serum-complement-c1q-are-risk-factors-for-hemodialysis-headache-a-case-control-study
#37
JOURNAL ARTICLE
Quan Gan, Lily Zhang, Yuting Fang, Liu Yang, Ming Shi, Zheman Xiao
BACKGROUND AND OBJECTIVE: Hemodialysis headache (HDH) is a common complication of dialysis that negatively affects the patient's quality of life. The etiology and triggering factors of HDH are not fully understood. This study aims to assess the prevalence and characteristics of HDH among patients undergoing hemodialysis across multiple centers in China. Furthermore, we conducted a case-control study at one hospital to identify risk factors associated with HDH. METHODS: The study consisted of two phases including a cross-sectional observational study and a case-control study...
March 2024: Headache
https://read.qxmd.com/read/38411625/blood-pressure-elevation-in-erenumab-treated-patients-with-migraine-a-retrospective-real-world-experience
#38
JOURNAL ARTICLE
Nikita Chhabra, Carolyn Mead-Harvey, Christopher A Dodoo, Courtney Iser, Hallie Taylor, Hira Chaudhary, Aimen Vanood, David W Dodick
BACKGROUND: Erenumab is a monoclonal antibody that targets the calcitonin gene-related peptide (CGRP) receptor and is approved for the preventative treatment of migraine in adults. CGRP is involved in the regulation of vasomotor tone under physiologic and pathologic conditions, including hypertension. While there has not been evidence of hypertension in preclinical models or clinical trials, post-marketing data suggest erenumab may be associated with hypertension. This led to a warning in the United States Food and Drug Administration prescribing information for erenumab...
March 2024: Headache
https://read.qxmd.com/read/38385643/long-term-outcomes-of-gamma-knife-radiosurgery-in-treating-glossopharyngeal-neuralgia
#39
JOURNAL ARTICLE
Yavuz Samanci, Elif Mürdün, Mahmut Çil, Ali Haluk Düzkalir, Mehmet Orbay Askeroglu, Selcuk Peker
Glossopharyngeal neuralgia (GPN) is an unusual disorder causing severe, brief pain episodes in the areas supplied by the glossopharyngeal nerve. Initial treatment involves medications like carbamazepine, but if these are ineffective or cause side effects, interventional pain management techniques or surgery may be considered. Gamma Knife radiosurgery is becoming popular in managing GPN due to its lower risk of complications than surgical interventions like microvascular decompression or rhizotomy. In this retrospective case series, we examined the outcomes of Gamma Knife radiosurgery in eight patients with GPN...
March 2024: Headache
https://read.qxmd.com/read/38299747/screen-time-and-pediatric-headache-a-scoping-review-of-the-literature
#40
REVIEW
Raquel L Langdon, Marc T DiSabella, Jeffrey A Strelzik
OBJECTIVE: The aim of this study was to summarize the evidence regarding screen use as a contributing factor in pediatric headache and migraine. BACKGROUND: Screen exposure is often reported as a headache trigger, though there is no current consensus in terms of how screen type, duration, or frequency influences pediatric headache and the associated burden of disease. METHODS: A systematic search in PubMed, Scopus, Cochrane Library, ProQuest Health and Medical Database, and Google Scholar was performed through November 2022 in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement...
February 2024: Headache
journal
journal
25525
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.